HNGE R&D to Revenue
Hinge Health, Inc. Class A Common Stock · R&D to Revenue
HNGE R&D to Revenue
Latest reported62.62%period ending
HNGE FY R&D/Revenue (37.60% → 62.62%)
Latest values, visible window
High-resolution chart · PNG
HNGE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 62.6232% | |
| 25.8294% | |
| 37.5971% |